使用枸橼酸铁铵抑制3D-MRCP图像中胃肠信号的初步研究

被引:16
作者
张立娜
徐克
任克
孙文阁
戚喜勋
金安玉
李延亮
机构
[1] 中国医科大学附属第一临床学院
[2] 中国医科大学附属第一临床学院 辽宁沈阳
关键词
磁共振胰胆管成像(MRCP); 反转时间(TI); 枸橼酸铁铵; 阴性造影剂; 阳性造影剂;
D O I
10.13929/j.1003-3289.2003.06.051
中图分类号
R445.2 [核磁共振成像];
学科分类号
100207 ;
摘要
目的 评价使用枸橼酸铁铵后 3D MRCP图像的改善程度。方法 本组共收集MRCP病人 3 0例。在服用枸橼酸铁铵前、后以相同的采集参数对其行 3D MRCP成像。图像评价从胃肠信号消除情况和图像质量改善情况两方面进行。结果 使用造影剂后胃部的对比信噪比由 7.0 64± 3 .85 3降至 1.0 41± 0 .45 9,十二指肠则由 5 .494± 3 .916降至 1.93 1± 2 .3 17,两者的P值均小于 0 .0 0 1;MRCP的图像质量由造影前的 2 .83 3± 2 .0 5 2增至 9.13 3± 2 .0 3 0 ,P <0 .0 0 1。结论 使用枸橼酸铁铵几乎可完全消除 3D MRCP图像中的胃肠信号 ,明显改善图像质量。
引用
收藏
页码:762 / 764
页数:2
相关论文
共 12 条
[1]  
MR Cholangiography and MR Urography: Improved Enhancement with A Negative Oral Contrast Agent. Hirohashi S,Hirohashi R,Uchida H,et al. Radiology . 1997
[2]  
High Concentration of Ferric Ammonium Citrate (FAC) Solution as A Negative Bowel Contrast Agent. Takahar T,Yoshikawa T,Saeki M,et al. Nippon Igaku Hoshasen Gakkai Zasshi . 1995
[3]  
Positive bowel contrast agent for MR imaging of the abdomen: Phase Ⅱand Ⅲ clinical trials. Patten RM,Lo SK,Phillips JJ,et al. Radiology . 1993
[4]  
Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen,safty and diagnostic efficacy. Kivelitz D,Gehl HB,Henck A,et al. Acta Radiologica Diagnosis . 1999
[5]  
Dilute Oral Iron Solutions as Gastrointestinal Contrast Agents for Magnetic Resonance Imaging: Initial Clinical Experience. Wesbey GE,Brasch RC,Goldberg HI,et al. Magnetic Resonance Imaging . 1985
[6]  
Examination of Intro-gastrointestinal Tract Signal Elimination in MRCP: Combined Use of T1shortening Positive Contrast Agent and Singleshot Fast Inversion Recovery. Kato J,Kamamura Y,Watanabe T,et al. Journal of Magnetic Resonance Imaging . 2001
[7]  
OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging, safty and imaging characteristics. Patten RM,Moss AA,Fenton TA,et al. Journal of Magnetic Resonance Imaging . 1992
[8]  
MR imaging oral contrast agent mixed with milk for the small intestine. Hirohashi S,Hirohashi R,Uchida H,et al. Nippon Igaku Hoshasen Gakkai. Zasshi . 1994
[9]  
Phase Ⅲstudy of an oral abdominal contrast agent containing Ferric ammonium citrate for magnestic resonance imaging(OMR-12200). Hirohashi S,Uchida H,Tanaka M,et al. Diag Treat . 1992
[10]  
The clinical value of Ferric ammonium citrate: a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen. Malcolm PN,Brown JJ,Hahn PF,et al. Journal of Magnetic Resonance Imaging . 2000